Suppression of ATR by VE-821 (ATRi) can affect HR repair in ovarian cancer cells, leading to accumulation of DNA DSBs in cell nuclei, thereby increasing the sensitivity of ovarian cancer SKOV-3 cells to cisplatin [58]. Here, ATR is linked to ovarian carcinoma.